Worldwide, hepatitis B virus is the major risk factor for hepatocellular carcinoma (HCC), owing to ... cause of HCC in the coming decades. Current surveillance regimes of α-fetoprotein and ...

China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...

Disparities in liver cancer risk and outcomes in the LGBTQ community: A literature review. Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A ...

(JAMA Network Open) A single-center trial favored non-contrast MRI over ultrasound for hepatocellular carcinoma (HCC) surveillance in patients with cirrhosis. (Gastroenterology) And for ...

Each guideline was checked for the following topics: prevention, screening and surveillance, diagnosis, clinical staging, curative treatment, trans-arterial therapies and systemic therapies.

CLINICAL complete response (cCR) is a strong predictor of prognosis in patients with unresectable hepatocellular carcinoma ...

Japanese researchers sought to build upon prior studies demonstrating the feasibility of liver resection in geriatric hepatocellular carcinoma patients, particularly in those undergoing major ...

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.